Literature DB >> 737618

Medical complications of obesity.

A Angel, D A Roncari.   

Abstract

Obesity leads to several complications that affect many body systems. This paper focuses mainly on the cardiovascular complications, which include coronary heart disease, cerebrovascular disease and stroke, and congestive heart failure; the last may be secondary not only to advanced coronary atherosclerosis, but also to other pathogenetic factors. The increased frequency of coronary heart disease in the obese is largely attributable to the commonly associated hypertension, diabetes mellitus and lipoprotein abnormalities, rather than the adiposity. The lipoprotein disorders that have a role in atherogenesis are decreased plasma concentrations of high-density lipoproteins and elevated plasma concentrations of low-density lipoproteins. Abnormalities in cholesterol metabolism are responsible for the increased frequency of cholelithiasis in obese persons. The factors that mediate the development of cardiovascular and gallbladder complications are correctable by an appropriate program of meal planning and physical activity.

Entities:  

Mesh:

Year:  1978        PMID: 737618      PMCID: PMC1818619     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  27 in total

1.  Protein-lipid relationships in human plasma. II. In atherosclerosis and related conditions.

Authors:  D P BARR; E M RUSS; H A EDER
Journal:  Am J Med       Date:  1951-10       Impact factor: 4.965

Review 2.  Current status of intestinal bypass surgery in the treatment of obesity.

Authors:  G A Bray
Journal:  Diabetes       Date:  1977-11       Impact factor: 9.461

3.  Chronic heart disease due to obesity.

Authors:  J K Alexander
Journal:  J Chronic Dis       Date:  1965-09

4.  Cardiovascular effects of weight reduction.

Authors:  J K Alexander; K L Peterson
Journal:  Circulation       Date:  1972-02       Impact factor: 29.690

5.  Diabetes, blood lipids, and the role of obesity in coronary heart disease risk for women. The Framingham study.

Authors:  T Gordon; W P Castelli; M C Hjortland; W B Kannel; T R Dawber
Journal:  Ann Intern Med       Date:  1977-10       Impact factor: 25.391

6.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.

Authors:  T Gordon; W P Castelli; M C Hjortland; W B Kannel; T R Dawber
Journal:  Am J Med       Date:  1977-05       Impact factor: 4.965

7.  Insulin receptor status in disease states of man.

Authors:  R S Bar; J Roth
Journal:  Arch Intern Med       Date:  1977-04

8.  Insulin secretion in obesity and diabetes: an illustrative case.

Authors:  S M Genuth
Journal:  Ann Intern Med       Date:  1977-12       Impact factor: 25.391

9.  Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients.

Authors:  E Reisin; R Abel; M Modan; D S Silverberg; H E Eliahou; B Modan
Journal:  N Engl J Med       Date:  1978-01-05       Impact factor: 91.245

10.  Insulin release and cyclic AMP accumulation in response to glucose in pancreatic islets of fed and starved rats.

Authors:  A Rabinovitch; V Grill; A E Renold; E Cerasi
Journal:  J Clin Invest       Date:  1976-11       Impact factor: 14.808

View more
  2 in total

1.  Obesity in family practice: is treatment effective?

Authors:  M D Sanborn; S R Manske; R P Schlegel
Journal:  Can Fam Physician       Date:  1983-03       Impact factor: 3.275

2.  Effectiveness and weight effects of open-label lamotrigine with and without concomitant psychotropic medications in patients with bipolar I disorder.

Authors:  Michael N Zarzar; Jay Graham; Jeremy Roberts; Thomas Thompson; Kevin Nanry
Journal:  MedGenMed       Date:  2007-05-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.